Opus Genetics (IRD) Cash from Financing Activities (2011 - 2026)
Opus Genetics' Cash from Financing Activities came in at $40.9 million for Q2 2026, compared with $906,000 a year earlier and up 48.2% from the prior quarter.
Powered by 
Analysis
Opus Genetics (IRD) Cash from Financing Activities (2011 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Opus Genetics reported Cash from Financing Activities of $97.15 million, up 348.9% year-over-year; for FY2025, it was $50.02 million.
- Cash from Financing Activities carries a five-year compound annual growth rate of 18.8% (FY2020 to FY2025).
- Going back by year, Cash from Financing Activities was $4.19 million in FY2024 (-53.4%), $8.98 million in FY2023 (+137.2%), $3.79 million in FY2022 (-86.3%) and $27.61 million in FY2021 (+30.7%).
- The Q2 2026 figure represents the highest quarterly Cash from Financing Activities in data going back to Q1 2011.
- Year-over-year, Cash from Financing Activities increased in two of the last four quarters, with growth averaging 165.4%.
- The fastest year-over-year change in Cash from Financing Activities over five years came in Q1 2025 (growth of 761.3%), and the weakest in Q3 2024 (a decline of 93.4%).
- Business Quant data shows IRD's Cash from Financing Activities at $27.6 million (Q1 2026), $24.11 million (Q4 2025) and $4.54 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | -8.78 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | -5.05 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 1.76 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -2.02 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -47.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | -1.48 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 2.34 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | -3.66 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | -426.70 Mn |
| 10 | Opus Genetics | 400.02 Mn | 175.30 Mn | - | 40.90 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 40.90 Mn |
| Mar 31, 2026 | 27.60 Mn |
| Dec 31, 2025 | 24.11 Mn |
| Sep 30, 2025 | 4.54 Mn |
| Jun 30, 2025 | 906,000.00 |
| Mar 31, 2025 | 20.47 Mn |
| Dec 31, 2024 | -83,000.00 |
| Sep 30, 2024 | 353,000.00 |
| Jun 30, 2024 | 1.54 Mn |
| Mar 31, 2024 | 2.38 Mn |
| Dec 31, 2023 | 3.60 Mn |
| Sep 30, 2023 | 5.38 Mn |
| Dec 31, 2022 | -12,000.00 |
| Sep 30, 2022 | 1.33 Mn |
| Jun 30, 2022 | 1.59 Mn |
| Mar 31, 2022 | 882,000.00 |
| Dec 31, 2021 | 8.03 Mn |
| Sep 30, 2021 | 1.60 Mn |
| Jun 30, 2021 | 17.97 Mn |
| Mar 31, 2021 | 10,000.00 |
API Access
Opus Genetics Cash from Financing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=IRD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-financing-activities", "ticker": "IRD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=IRD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();